Gemtuzumab ozogamicin plus midostaurin in conjunction with standard intensive therapy for FLT3-mutated acute myeloid leukemia patients - Czech center experience

被引：5
|
作者：
Weinbergerova, Barbora [1 ,2 ]
Cernan, Martin [3 ,4 ]
Kabut, Tomas [1 ,2 ]
Semerad, Lukas [1 ,2 ]
Podstavkova, Natalia [1 ,2 ]
Szotkowski, Tomas [3 ,4 ]
Jeziskova, Ivana
Mayer, Jiri [1 ,2 ]
机构：
[1] Masaryk Univ, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[2] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[3] Palacky Univ Olomouc, Fac Med & Dent, Dept Hemato Oncol, Olomouc, Czech Republic
[4] Univ Hosp Olomouc, Olomouc, Czech Republic
来源：
HAEMATOLOGICA | 2023年 / 108卷 / 10期
关键词：
CHEMOTHERAPY;
D O I：
10.3324/haematol.2022.282263
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2826 / 2829
页数：4
相关论文
共 50 条
  • [1] Midostaurin in FLT3-Mutated Acute Myeloid Leukemia
    Eskazan, A. Emre
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (19): : 1901 - 1901
  • [2] Idarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia
    Diebold, Kendall
    Bourne, Garrett
    Espinoza-Gutarra, Manuel
    Al-Kadhimi, Zaid
    Bachiashvili, Kimo
    Rangaraju, Sravanti
    Vachhani, Pankit
    Bhatia, Ravi
    Jamy, Omer
    LEUKEMIA & LYMPHOMA, 2024, 65 (11) : 1737 - 1739
  • [3] Midostaurin for the management of FLT3-mutated acute myeloid leukemia and advanced systemic mastocytosis
    Sly, Nichole
    Gaspar, Katie
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2019, 76 (05) : 268 - 274
  • [4] Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia
    Joudinaud, Romane
    Boudry, Augustin
    Fenwarth, Laurene
    Geffroy, Sandrine
    Salson, Mikael
    Dombret, Herve
    Berthon, Celine
    Pigneux, Arnaud
    Lebon, Delphine
    Peterlin, Pierre
    Bouzy, Simon
    Flandrin-Gresta, Pascale
    Tavernier, Emmanuelle
    Carre, Martin
    Tondeur, Sylvie
    Haddaoui, Lamya
    Itzykson, Raphael
    Bertoli, Sarah
    Bidet, Audrey
    Delabesse, Eric
    Hunault, Mathilde
    Recher, Christian
    Preudhomme, Claude
    Duployez, Nicolas
    Dumas, Pierre-Yves
    BLOOD ADVANCES, 2025, 9 (02) : 365 - 374
  • [5] Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia
    Daver, Naval
    Perl, Alexander E.
    Maly, Joseph
    Levis, Mark
    Ritchie, Ellen
    Litzow, Mark
    McCloskey, James
    Smith, Catherine C.
    Schiller, Gary
    Bradley, Terrence
    Tiu, Ramon, V
    Naqvi, Kiran
    Dail, Monique
    Brackman, Deanna
    Siddani, Satya
    Wang, Jing
    Chyla, Brenda
    Lee, Paul
    Altman, Jessica K.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (35) : 4048 - +
  • [6] Cost-effectiveness of midostaurin in the treatment of newly diagnosed FLT3-mutated acute myeloid leukemia in France
    Tremblay, Gabriel
    Cariou, Clemence
    Recher, Christian
    Dolph, Mike
    Brandt, Patricia
    Blanc, Anne-Sandrine
    Forsythe, Anna
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2020, 21 (04): : 543 - 555
  • [7] Invasive Mold Infections in FLT3-Mutated Acute Myeloid Leukemia
    Phoompoung, Pakpoom
    Henry, Benoit
    Daher-Reyes, Georgina
    Sibai, Hassan
    Husain, Shahid
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (05): : E477 - E482
  • [8] CPX-351 in FLT3-mutated acute myeloid leukemia
    Andrews, Claire
    Pullarkat, Vinod
    Recher, Christian
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Gilteritinib combination therapies in pediatric patients with FLT3-mutated acute myeloid leukemia
    McCall, David
    Roth, Michael
    Mahadeo, Kris M.
    Toepfer, Laurie
    Nunez, Cesar
    Short, Nicholas J.
    Daver, Naval
    Kadia, Tapan M.
    DiNardo, Courtney
    Yi, Joanna S.
    Cuglievan, Branko
    BLOOD ADVANCES, 2021, 5 (23) : 5215 - 5219
  • [10] Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib
    Perl, Alexander E.
    Hosono, Naoko
    Montesinos, Pau
    Podoltsev, Nikolai
    Martinelli, Giovanni
    Panoskaltsis, Nicki
    Recher, Christian
    Smith, Catherine C.
    Levis, Mark J.
    Strickland, Stephen
    Rollig, Christoph
    Gross-Langenhoff, Marco
    Chou, Wen-Chien
    Lee, Je-Hwan
    Yokoyama, Hisayuki
    Hasabou, Nahla
    Lu, Qiaoyang
    Tiu, Ramon, V
    Altman, Jessica K.
    BLOOD CANCER JOURNAL, 2022, 12 (05)
12345